Details of the Drug Combinations

General Information of This Drug (ID: DM4IF32)

• Drug Name: Pyrazinamide (DM4IF32)
• Synonyms: Aldinamid; Aldinamide; Braccopiral; Corsazinmid; Dipimide; Eprazin; Farmizina; Isopas; Lynamide; Novamid; Pezetamid; Pharozinamide; Piraldina; Pirazimida; Pirazinamid; Pirazinamida; Pirazinamide; Prazina; Pyrafat; Pyramide; Pyrazide; Pyrazinamdie; Pyrazinamidum; Pyrazineamide; Pyrazinecarboxamide; Rozide; Tebrazid; Tebrazio; Tisamid; Unipyranamide; Zinamide; Zinastat; P ezetamid; Pirazinamide [DCIT]; Pyrazine carboxamide; Pyrazine carboxylamide; Pyrazinecarboxylic acid amide; Pyrazinoic acid am ide; Pyrazinoic acid amide; DRG 0124; MK 56; P 7136; Pyrazinamide BP 2000; T 165; AZT + Pyrazinamide combination; D-50; Pirazinamida [INN-Spanish]; Pms-Pyrazinamide; Pyrazinamide (TN); Pyrazinamidum [INN-Latin]; D-50 (VAN); Pyrazinamide [INN:BAN:JAN]; Pyrazine-2-carboxamide; Pyrazinamide (JP15/USP/INN); Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide; 2-Carbamylpyrazine; 2-carbamyl pyrazine

Indication

Meningeal tuberculosis; ICD 11: N.A.; Status: Approved [1]; Mycobacterium infection; ICD 11: 1B10-1B21; Status: Approved [2]; Pulmonary tuberculosis; ICD 11: 1B10.Z; Status: Approved [1]

• Therapeutic Class: Antitubercular Agents
• Drug Type: Small molecular drug

List of Combinatorial Drugs (CBD) Containing This Drug

123 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Pyrazinamide + Meclofenamic acid	DCRKPRU	Meclofenamic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Ribavirin-TP	DCHUH8D	Ribavirin-TP	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Ribavirin-TP	DCCKDDD	Ribavirin-TP	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Sertraline	DC9F88B	Sertraline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Mebutamate	DCOTSCS	Mebutamate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Picoplatin	DCV2V9S	Picoplatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Primidone	DC71TD6	Primidone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Dantrolene	DC4P3HO	Dantrolene	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Diethylcarbamazine	DCECNAM	Diethylcarbamazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + PD-0325901	DCUMW4V	PD-0325901	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + AT13387	DCDBBKI	AT13387	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Kanamycin	DCV0TNH	Kanamycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Citalopram	DCXX5LO	Citalopram	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Imipramine	DCZ9JBP	Imipramine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Dactinomycin	DC7NGS3	Dactinomycin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Terazosin	DCSV44G	Terazosin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Tindamax	DCF6VJD	Tindamax	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Furazolidone	DCQNJEK	Furazolidone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Chlorphenesin	DCSIV76	Chlorphenesin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + MK-1775	DCAV3PJ	MK-1775	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Carfilzomib	DC1HOAM	Carfilzomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + PMID28460551-Compound-2	DCVP3G6	PMID28460551-Compound-2	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Methotrexate	DC0JX6R	Methotrexate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Repaglinide	DCEGS4V	Repaglinide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Vinblastine	DCHWJTN	Vinblastine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Mephenytoin	DC7TKKP	Mephenytoin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Ixazomib	DCFFK7I	Ixazomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Anamorelin	DCL028O	Anamorelin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Alvespimycin hydrochloride	DCANT7X	Alvespimycin hydrochloride	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + LY2835219	DCETMM9	LY2835219	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Pepstatin	DCBL4OJ	Pepstatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + IT-141	DC2E8W9	IT-141	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Pamidronate	DCC6C0N	Pamidronate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Methylergonovine	DCXJR1A	Methylergonovine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Palonosetron	DCGGMB2	Palonosetron	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Isosorbide dinitrate	DCEMW7B	Isosorbide dinitrate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Buspirone	DCXMBAX	Buspirone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Metyrosine	DCD175A	Metyrosine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Efavirenz	DCLCKLS	Efavirenz	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Terameprocol	DCZ2WI1	Terameprocol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Guanfacine	DCB14WC	Guanfacine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + SCH 727965	DC2C8MT	SCH 727965	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Doxapram	DC3XNYI	Doxapram	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Chlorzoxazone	DC7KDXV	Chlorzoxazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Plinabulin	DCVHSTF	Plinabulin	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Metformin	DCT8UJS	Metformin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Docetaxel	DC90UH0	Docetaxel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Phenprocoumon	DCS3PBR	Phenprocoumon	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Cilastatin	DCMTAGF	Cilastatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Methoxsalen	DC5UU8V	Methoxsalen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Marizomib	DC3V94C	Marizomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Galantamine	DCLLMJH	Galantamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Ginsenoside Rb1	DCQ0OCD	Ginsenoside Rb1	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Daidzin	DC6QHX3	Daidzin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Phensuximide	DCAMRF8	Phensuximide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + VR-776	DCCMWB2	VR-776	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Armodafinil	DCCXNP9	Armodafinil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Ciprofibrate	DCVANTE	Ciprofibrate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Nizatidine	DCJOQ8H	Nizatidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Naringenin	DCA2SPD	Naringenin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Clopidogrel	DC01WJP	Clopidogrel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Diphenidol	DCS3WGY	Diphenidol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Pentamidine	DC9EFOL	Pentamidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Bosentan	DC97R26	Bosentan	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Sulfapyridine	DCZMN5Z	Sulfapyridine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Triflupromazine	DC2V2DL	Triflupromazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + BIO-300	DCHEFFL	BIO-300	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Niclosamide	DCIBPD9	Niclosamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Eflornithine	DC18XVL	Eflornithine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Isoproterenol	DC908LT	Isoproterenol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Etonogestrel	DCBFKLA	Etonogestrel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Trifluoperazine	DCL6407	Trifluoperazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Tiagabine	DCBBQLP	Tiagabine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + GINKGOLIDE A	DCZZTJG	GINKGOLIDE A	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Diazoxide	DCJQ500	Diazoxide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Fenoprofen	DCALOZB	Fenoprofen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Ridaforolimus	DCJWIP3	Ridaforolimus	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Allopurinol	DCI14XG	Allopurinol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Benserazide	DCPGG84	Benserazide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Pargyline	DCN19JN	Pargyline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Idarubicin	DCJ5QKU	Idarubicin	Glioblastoma? (Cell Line: T98G)	[3]
Pyrazinamide + Methocarbamol	DC2T3E8	Methocarbamol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + ONC201	DCLNWMA	ONC201	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Imatinib	DCAUT2A	Imatinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Probenecid	DCMT5Q7	Probenecid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Abacavir	DCPRX90	Abacavir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + LEE011	DCZSP0W	LEE011	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Pramipexole	DCH1OXP	Pramipexole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Methylene blue	DCJ5XI1	Methylene blue	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Moricizine	DCHH6FJ	Moricizine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Clascoterone	DCW6OUM	Clascoterone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Dopamine	DCASF80	Dopamine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Oxyphenbutazone	DCCN49K	Oxyphenbutazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Teriflunomide	DCB5SS3	Teriflunomide	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Pyrazinamide + Acetohexamide	DC0S1VT	Acetohexamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Leflunomide	DCRUWRN	Leflunomide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Novobiocin	DCLANX8	Novobiocin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Theophylline	DC2U92O	Theophylline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Acarbose	DCHICDH	Acarbose	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Brincidofovir	DCN5QTZ	Brincidofovir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Amantadine	DCEXR7C	Amantadine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Asenapine	DCLNE1Q	Asenapine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Naltrexone	DCKLOT4	Naltrexone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Quinine	DC84ASJ	Quinine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Oxandrolone	DCPDU8Y	Oxandrolone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Lacosamide	DCG31D1	Lacosamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Iloprost	DCU85BD	Iloprost	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Nabilone	DCHSIB9	Nabilone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Silver sulfadiazine	DCELTGL	Silver sulfadiazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Olmesartan medoxomil	DCN0F75	Olmesartan medoxomil	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + PMID28870136-Compound-43	DCP5QY5	PMID28870136-Compound-43	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Cevimeline	DCDK472	Cevimeline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Estramustine	DC1PJNR	Estramustine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Metaxalone	DC86MZX	Metaxalone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Hydroxychloroquine	DCNCLE9	Hydroxychloroquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Atovaquone	DC03WQZ	Atovaquone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + ML323	DCSDCCT	ML323	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Raltegravir	DCEYC9T	Raltegravir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + GSK2194069	DCJKHZN	GSK2194069	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Tacrolimus	DCUCC99	Tacrolimus	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Tetracycline	DCY7H4N	Tetracycline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Cytarabine	DC6IQXM	Cytarabine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]
Pyrazinamide + Etomidate	DCHJFX1	Etomidate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[3]

40 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Bedaquiline + Pyrazinamide	DCZDPWB	Bedaquiline	Pulmonary Tuberculosis	[4]
Pyrazinamide + Isoniazid	DC9I6BF	Isoniazid	HIV Infections	[5]
Pyrazinamide + Rifampicin	DCINLE8	Rifampicin	HIV Infections	[5]
Pyrazinamide + Rifampicin	DCUYWK5	Rifampicin	Pulmonary Tuberculosis	[6]
Pyrazinamide + Pretomanid	DCA3OI7	Pretomanid	Pulmonary Tuberculosis	[4]
Pyrazinamide + Allopurinol	DC2MOZL	Allopurinol	Tuberculosis	[7]
Pyrazinamide + Celecoxib	DCJ20NX	Celecoxib	Tuberculosis	[8]
Bedaquiline + Pyrazinamide	DC04ZDQ	Bedaquiline	Tuberculosis, Pulmonary	[9]
Bedaquiline + Pyrazinamide	DCDLBJZ	Bedaquiline	Pulmonary Tuberculosis	[10]
Bedaquiline + Pyrazinamide	DCFX2VP	Bedaquiline	Tuberculosis, Pulmonary	[11]
Bedaquiline + Pyrazinamide	DCLYUYV	Bedaquiline	Tuberculosis, Pulmonary	[12]
Bedaquiline + Pyrazinamide	DCV7C4N	Bedaquiline	Tuberculosis	[13]
Bedaquiline + Pyrazinamide	DCCKTXG	Bedaquiline	Pulmonary Tuberculosis	[10]
Bedaquiline + Pyrazinamide	DCDBKWI	Bedaquiline	Tuberculosis	[13]
Bedaquiline + Pyrazinamide	DCQR6Q4	Bedaquiline	Pulmonary Tuberculosis	[10]
Linezolid + Pyrazinamide	DCMOGRU	Linezolid	Tuberculosis, Multidrug-Resistant	[14]
Linezolid + Pyrazinamide	DCXMY9S	Linezolid	Tuberculous Meningitis	[15]
Pyrazinamide + Rifampicin	DC12V6F	Rifampicin	Pulmonary Tuberculosis	[6]
Pyrazinamide + Rifampicin	DC1OE7W	Rifampicin	Tuberculosis, Pulmonary	[12]
Pyrazinamide + Rifampicin	DC3RVJ3	Rifampicin	Pulmonary Tuberculosis	[16]
Pyrazinamide + Rifampicin	DCHBK4S	Rifampicin	Tuberculous Meningitis	[15]
Pyrazinamide + Rifampicin	DCL3W1O	Rifampicin	Tuberculosis, Pulmonary	[17]
Pyrazinamide + Rifampicin	DCM10XF	Rifampicin	HIV	[18]
Pyrazinamide + Rifampicin	DCS8QNC	Rifampicin	Tuberculosis	[19]
Pyrazinamide + Rifampicin	DCV4XRW	Rifampicin	Pulmonary Tuberculosis	[20]
Pyrazinamide + Rifampicin	DC0032N	Rifampicin	Tuberculosis	[19]
Pyrazinamide + Pretomanid	DC08G4C	Pretomanid	Pulmonary Tuberculosis	[21]
Pyrazinamide + Rifampicin	DCP9KAD	Rifampicin	Pulmonary Tuberculosis	[20]
Pyrazinamide + Rifampicin	DCW719W	Rifampicin	Tuberculosis, Pulmonary	[17]
Rifabutin + Pyrazinamide	DCRGZZB	Rifabutin	Pulmonary Tuberculosis	[16]
Linezolid + Pyrazinamide	DCG8UGE	Linezolid	Tuberculosis Multi Drug Resistant Active	[22]
Pyrazinamide + Isoniazid	DC23JKL	Isoniazid	Tuberculosis	[23]
Pyrazinamide + Rifampicin	DC32Y86	Rifampicin	Tuberculosis	[24]
Pyrazinamide + Isoniazid	DC9AJPI	Isoniazid	Tuberculosis	[23]
Pyrazinamide + Clofazimine	DCGTTEP	Clofazimine	Tuberculosis, Multidrug-Resistant	[25]
Pyrazinamide + Rifampicin	DCLTLMK	Rifampicin	Pulmonary Tuberculosis	[26]
Pyrazinamide + Isoniazid	DCM3RK9	Isoniazid	Tuberculosis, Pulmonary	[27]
Pyrazinamide + Rifampicin	DCMBY9E	Rifampicin	Tuberculosis, Pulmonary	[28]
Pyrazinamide + Pretomanid	DCI1QMJ	Pretomanid	Tuberculosis, Pulmonary, Drug Sensitive	[29]
Pyrazinamide + Rifampicin	DCE7UI3	Rifampicin	Tuberculosis, Pulmonary	[30]

References

• [1] Pyrazinamide FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7287).
• [3] Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
• [4] ClinicalTrials.gov (NCT01215851) Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)
• [5] ClinicalTrials.gov (NCT00042289) Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
• [6] ClinicalTrials.gov (NCT02554318) Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
• [7] ClinicalTrials.gov (NCT02700347) Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
• [8] ClinicalTrials.gov (NCT02602509) Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
• [9] ClinicalTrials.gov (NCT05556746) Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
• [10] ClinicalTrials.gov (NCT01691534) Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z). U.S. National Institutes of Health.
• [11] ClinicalTrials.gov (NCT03338621) Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
• [12] ClinicalTrials.gov (NCT05766267) Short-course Regimens for the Treatment of Pulmonary Tuberculosis
• [13] ClinicalTrials.gov (NCT02193776) A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.
• [14] ClinicalTrials.gov (NCT02619994) Treatment Shortening of MDR-TB Using Existing and New Drugs
• [15] ClinicalTrials.gov (NCT05383742) Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
• [16] ClinicalTrials.gov (NCT02256696) Assessing PA-824 for Tuberculosis (the APT Trial)
• [17] ClinicalTrials.gov (NCT01785186) Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
• [18] ClinicalTrials.gov (NCT04311502) Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
• [19] ClinicalTrials.gov (NCT01589497) Essentiality of INH in TB Therapy
• [20] ClinicalTrials.gov (NCT05807399) PanACEA - STEP2C -01
• [21] ClinicalTrials.gov (NCT01498419) Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
• [22] ClinicalTrials.gov (NCT02975570) Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
• [23] ClinicalTrials.gov (NCT02563327) Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
• [24] ClinicalTrials.gov (NCT00130247) Tuberculosis Treatment Shortening Trial
• [25] ClinicalTrials.gov (NCT02754765) Evaluating Newly Approved Drugs for Multidrug-resistant TB
• [26] ClinicalTrials.gov (NCT02581527) A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis
• [27] ClinicalTrials.gov (NCT05454345) Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
• [28] ClinicalTrials.gov (NCT04485156) Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
• [29] ClinicalTrials.gov (NCT02342886) Shortening Treatment by Advancing Novel Drugs. U.S. National Institutes of Health.
• [30] ClinicalTrials.gov (NCT02901288) Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis